Briefing: FDA’s top infectious disease regulator to depart agency
Strategic angle: Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is leaving the agency.
Browse the full archive, newest first.
Strategic angle: Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is leaving the agency.
Strategic angle: The i4 will reportedly be phased out next year as the company focuses on the new i3.
Strategic angle: Researchers at KAIST uncover how removing circular RNA can enhance longevity in C. elegans.
Strategic angle: Physicists create equilibrium glassy phase from rod-shaped particles, challenging traditional views on glass behavior.
Strategic angle: 'Put ngk spark plugs in man not the a premium.'
Strategic angle: The contract is for 20 hypersonic flight missions over four years.
Strategic angle: Rumors of American soldiers refusing to fight in Iran lack evidence, despite rising concerns.
Strategic angle: While no one expected the Fed to cut — much less hike — at this meeting, the market always looks for clues about what's next.
Strategic angle: A breakthrough in carbon dioxide conversion technology could pave the way for more efficient synthetic fuel production.